Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium.
about
Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted deliveryCo-opting biology to deliver drugsIntegrin targeted delivery of chemotherapeuticsDendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.RGD-avidin-biotin pretargeting to alpha v beta 3 integrin enhances the proapoptotic activity of TNF alpha related apoptosis inducing ligand (TRAIL).Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticlesDesign and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.Specific delivery of kinase inhibitors in nonmalignant and malignant diseases.Atomic force microscopy probing of receptor-nanoparticle interactions for riboflavin receptor targeted gold-dendrimer nanocomposites.Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells.Dendrimer-based macromolecular conjugate for the kidney-directed delivery of a multitargeted sunitinib analogue.Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery.Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injury.Biomolecular interaction study of Cyclolinopeptide A with human serum albumin.
P2860
Q33640942-C4F42114-F6B2-44AA-ADCD-16D4633210D5Q34424045-D4B3A31A-B67A-4795-81AB-78DB3072A8D3Q34912725-335D0DD1-F575-4022-B814-A56C7A20AEC8Q35624762-A1FD9E0D-44E5-414A-8475-DC909F308DBDQ36412875-4E55AE73-0222-4BEC-8911-2DC98373EC23Q37198647-0CA77550-BFF3-4605-94E8-DCDBE9B035C9Q37383231-4E8953D9-00D4-4641-B5A2-1F9B720A12BFQ37960141-30C531A7-5B58-4FD0-AFCC-E04F0F398A6EQ38705194-04FD3D9A-4095-462F-82EB-BCC5C52BF4FAQ39396441-4625FB00-1E68-4A2D-819D-CA275BBA79F5Q39697618-FBDBC250-1E5F-4587-901D-5F2BCAE4F04AQ41104930-302EBC8A-1330-4CB3-B195-888A1EFC93D6Q41886605-6611D1D9-8754-497B-A7EC-81DA2583C022Q42042555-DED5BDFE-4B2D-475B-A2B8-702A03044915
P2860
Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Rational design of RGD-albumin ...... 787 to angiogenic endothelium.
@ast
Rational design of RGD-albumin ...... 787 to angiogenic endothelium.
@en
type
label
Rational design of RGD-albumin ...... 787 to angiogenic endothelium.
@ast
Rational design of RGD-albumin ...... 787 to angiogenic endothelium.
@en
prefLabel
Rational design of RGD-albumin ...... 787 to angiogenic endothelium.
@ast
Rational design of RGD-albumin ...... 787 to angiogenic endothelium.
@en
P2093
P356
P1433
P1476
Rational design of RGD-albumin ...... K787 to angiogenic endothelium
@en
P2093
Gyorgy Kéri
Kai Temming
Klaas Poelstra
Marie Lacombe
Robbert J Kok
Roel Q J Schaapveld
P304
P356
10.1002/CMDC.200600201
P577
2006-11-01T00:00:00Z